"Dzhakavi" isasetyenziswa (ruksolitinib) ixabiso. Apho ukuthenga Dzhakavi kubiza

Ichiza elitsha "Dzhakavi" iveliswayo inkampani Swiss "Novartis" kuthandeka oogqirha abanyanga isifo somhlaza.

Ruksolitinib, eyona nto iphambili asebenzayo athi uthetha - iproteni tyrosine kinase inhibitor. Kuyinto sisebenzayo unyango lwezifo enxulumene ne splenomegaly, myelofibrosis kwakunye (kubandakanywa zamabanga aphakamileyo, awathi ngenxa thrombocythemia eziyimfuneko kunye polycythemia).

Abaphandi uqaphele ukuba ukusetyenziswa imadlana iziyobisi ubungakanani udakada nge-35%, ukunyuka kweminyaka yokuphila nezinga. Ngaloo ubuthi isithako esebenzayo ilindele eliphakathi kuthelekiswa namanye amachiza of spectrum efanayo amanyathelo.

Apho unako "Dzhakavi" iipilisi ukuthenga kubiza

Kodwa phambi kokuba kuqhutyelwe phambili inkcazelo ichiza, ngeke sithethe malunga unyango lwezifo ezinkulu kufuna okuninzi iziyobisi eninzi, yaye oku kodwa kubangela inkxalabo phakathi izigulane. Bashiye amayeza ebalulekileyo akwenzeki, kodwa ukuze nabo Kudla ngokuba nzima kakhulu. Ngoko, kwi drugstores ka eMoscow ku ipilisi "ixabiso Dzhakavi 'iqala 100 000 engange.

Awayihlangula kule meko kuza site WWW.ONKO24.COM apho unako ukuthenga ichiza generic ebizwa. Xa ukufana lugqityiwe, yaye isenjalo isicelo lubekelwe sitshiphu. Inyaniso yokuba imveliso generic ongazaliyo iindleko zokuphuhlisa, izixhobo zovavanyo, kunye nokukhuthazwa evumela abenzi zayo zokusebenza phantsi mvume esemthethweni, ukuba ahlawule emva kokukhutshwa amachiza ngexabiso eliphantsi.

ukulungiselela umthamo kunye nedosi

Izigulane kufuneka bazi ukuba ukusetyenziswa "Dzhakavi" ichiza ezimeleyo ekudleni. Ukuba ngelo xesha libekiweyo lokuba isiselo ayiphumelelanga tablet, awukwazi ukuthatha ithamo kabini kubo. Akukho mfuneko ngenxa yale ukwahluka ulwamkelo elandelayo.

Ithamo yokuqala iimveliso ezichazwe ezimiselwe kuphela oyingcali, kuxhomekeka parameters igazi - ukubala zegazi. Ngokuqhelekileyo, akukho 15 mg (p athathe 2 ngosuku.), Kuquka 100-200 / NL, ngelixa imali engaphezulu kwama-200 / NL - 20 mg. Ukuba inani zegazi yi 50-100 / NL, idosi iphezulu lokuqala kufuneka ingadluli 5 mg kabini ngemini. Ithamo liphezulu liya amabango ehlonyelwe "Dzhakavi" imiyalelo kweziyobisi zokusetyenziswa mayingagqithi 25 mg, kuhluthwa kabini yonke imihla.

Ngokubanzi, unyango kufuneka wenziwe ukubala ruksolitinibom rhoqo iiseli egazini (erythrocytes, leukocytes neeplatelets) kwiiveki 2-4 ngexesha kukhethwe ithamo kwaye ngoko, kuxhomekeka izikhokelo ezivela eklinikhi.

Izimo

Ukuba ukusetyenziswa kweziyobisi "Dzhakavi" kukho Izimo ezithile:

1. Ukukhulelwa ne zisanyisa.
2. yobudala Nomonde ongaphantsi kweminyaka elishumi elinesibhozo ubudala.
3. nobandlululo ruksolitiniba Personal okanye enye inxalenye yokulungiselela.

Njengoko kuchaziwe kwi isicelo of "Dzhakavi" iimpendulo leengcali ezikhoyo, ithetha kufuneka isetyenziswe ngobulumko xa unyango kwezigulane ukusilela kwezintso okanye esikhumbeni. In kuhlobo olufanayo kwaye ziquka izigulane thrombocytopenia, neutropenia kunye nezinye.

imiphumela emibi

Xa isicelo, njengoko kubonisiwe apha ukuba "Dzhakavi" umyalelo, amaxesha amaninzi waphawula zilandelayo reactions ezibi:

• izifo womchamo;
• igazi;
• neutrophils;
• thrombocytopenia;
• ukopha (kubandakanywa bazigruzule, impumlo kunye ukopha intracranial kunye legazi kwisiqwenga zesisu);
• umzimba;
• nesiyezi;
• hypercholesterolemia;
• ebuhlungu.